Article Information
History
- March 29, 2023.
Article Versions
- Version 1 (January 6, 2022 - 18:06).
- Version 2 (April 22, 2022 - 03:56).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Etienne Sollier1,2,
- Jack Kuipers1,3,
- Koichi Takahashi4,5,
- Niko Beerenwinkel1,3 and
- Katharina Jahn1,3,6,*
- 1Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland
- 2Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
- 3SIB Swiss Institute of Bioinformatics, Basel, Switzerland
- 4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 5Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 6Department of Mathematics and Computer Science, Freie Universität Berlin, Berlin, Germany
- ↵*Corresponding author
, Correspondence to Katharina Jahn. katharina.jahn{at}bsse.ethz.ch